Health is our business
3 Oct/ 0 Comment
PROSTIN VR drug usage training webinar in collaboration with the neonatal group of Namazi Hospital in Shiraz, Pfizer Company
On May 29th, a training webinar on the use of PROSTIN VR was held with the presence of professors and assistants in the neonatal ward of Namazi Hospital. At the beginning of the session, Dr. Roya Aboudi (neonatal specialist) spoke about the need to maintain the arterial duct and the role of drug interactions to maintain arterial blood flow. Then, Dr. Azadeh Ghiaei, Medical Representative of Pfizer Company, introduced PROSTIN VR drug and the place of using this drug in temporarily keeping the arterial duct open in infants with congenital heart defects. Also, the availability of this drug in that center and how to use the drug and the dosage of it was fully explained in the presence of professors and assistants in the neonatal intensive care unit. At the end of the program, the questions were answered.